These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2826851)

  • 41. Procollagen-III peptide and chronic viral C hepatitis.
    Jeffers LJ; Coelho-Little ME; Cheinquer H; Vargas C; Civantos F; Alvarez L; Reddy KR; Parker T; de Medina M; Li X
    Am J Gastroenterol; 1995 Sep; 90(9):1437-40. PubMed ID: 7661165
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of malotilate treatment on alcoholic liver disease.
    Takase S; Matsuda Y; Yasuhara M; Takada A
    Alcohol; 1989; 6(3):219-22. PubMed ID: 2544209
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Noninvasive evaluation of hepatic fibrosis using serum fibrotic markers, transient elastography (FibroScan) and real-time tissue elastography.
    Tatsumi C; Kudo M; Ueshima K; Kitai S; Takahashi S; Inoue T; Minami Y; Chung H; Maekawa K; Fujimoto K; Akiko T; Takeshi M
    Intervirology; 2008; 51 Suppl 1():27-33. PubMed ID: 18544945
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum procollagen type III peptide levels in patients with acute viral hepatitis.
    Annoni G; Donato MF; Cantaluppi C; Lampertico P; Cargnel A; Viganò P; Hahn EG; Colombo M
    Ric Clin Lab; 1988; 18(1):37-44. PubMed ID: 3375738
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Significance of prolyl hydroxylase analysis in clinical tests].
    Yamada S; Kawasaki H
    Nihon Rinsho; 1989 Dec; 48 Suppl():321-3. PubMed ID: 2560079
    [No Abstract]   [Full Text] [Related]  

  • 46. Comparison of serum procollagen III peptide concentrations and PGA index for assessment of hepatic fibrosis.
    Teare JP; Sherman D; Greenfield SM; Simpson J; Bray G; Catterall AP; Murray-Lyon IM; Peters TJ; Williams R; Thompson RP
    Lancet; 1993 Oct; 342(8876):895-8. PubMed ID: 8105167
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic value of serum procollagen III peptide and type IV collagen in patients with biliary atresia.
    Kobayashi H; Miyano T; Horikoshi K; Tokita A
    J Pediatr Surg; 1998 Jan; 33(1):112-4. PubMed ID: 9473113
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum markers for connective tissue turnover in patients with chronic hepatitis B and chronic hepatitis C: a comparative analysis.
    Murawaki Y; Ikuta Y; Nishimura Y; Koda M; Kawasaki H
    J Hepatol; 1995 Aug; 23(2):145-52. PubMed ID: 7499785
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Correlation of serum markers with fibrosis staging in chronic viral hepatitis].
    Wang T; Wang B; Liu X
    Zhonghua Bing Li Xue Za Zhi; 1998 Jun; 27(3):185-90. PubMed ID: 11244978
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum aminoterminal propeptide of type III procollagen in psoriasis and psoriatic arthritis: relation to liver fibrosis and arthritis.
    Zachariae H; Aslam HM; Bjerring P; Søgaard H; Zachariae E; Heickendorff L
    J Am Acad Dermatol; 1991 Jul; 25(1 Pt 1):50-3. PubMed ID: 1880254
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Assay of an amino propeptide of procollagen III in hepatic pathology].
    Lefrère JJ; Arrago JP; Poirier O; Najean Y
    Ann Med Interne (Paris); 1987; 138(8):667. PubMed ID: 3450217
    [No Abstract]   [Full Text] [Related]  

  • 52. Serum concentrations of the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen in chronic liver disease.
    Hayasaka A; Iida S; Ohto M
    Clin Chim Acta; 1995 Jun; 238(1):85-90. PubMed ID: 7554298
    [No Abstract]   [Full Text] [Related]  

  • 53. Serum markers for hepatic fibrosis in alcoholic liver disease: which is the best marker, type III procollagen, type IV collagen, laminin, tissue inhibitor of metalloproteinase, or prolyl hydroxylase?
    Tsutsumi M; Takase S; Urashima S; Ueshima Y; Kawahara H; Takada A
    Alcohol Clin Exp Res; 1996 Dec; 20(9):1512-7. PubMed ID: 8986196
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aminoterminal propeptide of type III procollagen in methotrexate-induced liver fibrosis and cirrhosis.
    Risteli J; Søgaard H; Oikarinen A; Risteli L; Karvonen J; Zachariae H
    Br J Dermatol; 1988 Sep; 119(3):321-5. PubMed ID: 3179204
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Collagen biosynthesis enzymes in serum and hepatic tissue in liver disease. I. Prolyl hydroxylase.
    Kuutti-Savolainen ER; Risteli J; Miettinen TA; Kivirikko KI
    Eur J Clin Invest; 1979 Feb; 9(1):89-95. PubMed ID: 222594
    [No Abstract]   [Full Text] [Related]  

  • 56. alpha-Interferon in the treatment of chronic viral hepatitis: effects on fibrogenesis serum markers.
    Capra F; Casaril M; Gabrielli GB; Tognella P; Rizzi A; Dolci L; Colombari R; Mezzelani P; Corrocher R; De Sandre G
    J Hepatol; 1993 Apr; 18(1):112-8. PubMed ID: 8340603
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aminoterminal propeptide of type III procollagen: a marker of disease activity in schistosomal patients.
    Fayol V; Hassanein HI; el-Badrawy N; Ville G; Hartmann DJ
    Eur J Clin Chem Clin Biochem; 1991 Nov; 29(11):737-41. PubMed ID: 1782280
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Serum level of N-terminal peptide of procollagen type III in chronic liver disease].
    Lee CM; Liaw YF; Huang MJ; Chen TJ; Chu CM; Sheen IS; Lin HH
    Taiwan Yi Xue Hui Za Zhi; 1987 Jul; 86(7):769-73. PubMed ID: 3681243
    [No Abstract]   [Full Text] [Related]  

  • 59. Evaluation of hepatic fibrosis by serum proline and amino-terminal type III procollagen peptide levels in alcoholic patients.
    Tanaka Y; Minato Y; Hasumura Y; Takeuchi J
    Dig Dis Sci; 1986 Jul; 31(7):712-7. PubMed ID: 3720468
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum procollagen type III peptide in chronic hepatitis B. Relationship to disease activity and response to interferon-alpha therapy.
    Giustina G; Fattovich G; De Paoli M; Guido M; Favarato S; Rugge M; Alberti A; Ruol A; Plebani M
    Int J Clin Lab Res; 1996; 26(1):33-6. PubMed ID: 8739853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.